Clinical Trials

NCT07087054 | RECRUITING | PHASE3
141 participants

Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-11-19
Completion:
2027-08-31
Conditions
  • Carcinoid Syndrome
  • Carcinoid
  • Carcinoid Tumor
  • Carcinoid Tumor of Ileum
  • Carcinoid Tumor of Cecum
  • Carcinoid Tumor of Liver
  • Carcinoid Tumor of Pancreas
  • Carcinoid Syndrome Diarrhea
  • Carcinoid Intestine Tumor
Interventions
  • DRUG
No Results Yet
NCT07016230 | ACTIVE_NOT_RECRUITING | PHASE2
40 participants

Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and Other Poorly Differentiated Neuroendocrine Carcinomas (NECs), With Biomarker Analysis to Characterize Response/Resistance (UNLOCK TARLATAMAB)

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-07-02
Completion:
2026-10-18
Conditions
  • Metastatic/Locally Advanced Small-Cell Lung Cancer
  • Metastatic/Locally Advanced Poorly Differentiated NEC
  • Metastatic/Locally Advanced High-grade MTC
Interventions
  • DRUG
No Results Yet
NCT06994520 | ENROLLING_BY_INVITATION | PHASE2
60 participants

Efficacy of Topical Cannabidiol for Eczema

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-05-01
Completion:
2027-08-01
Conditions
  • Chronic Pruritus
  • Eczema
  • Nummular Eczema
  • Atopic Dermatitis
  • Prurigo Nodularis
Interventions
  • OTHER
  • DRUG
No Results Yet
NCT06980038 | RECRUITING | PHASE2
44 participants

Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2026-05-27
Completion:
2027-11-24
Conditions
  • Head and Neck Squamous Cell Carcinoma
  • Hypopharyngeal Squamous Cell Carcinoma
  • Laryngeal Squamous Cell Carcinoma
  • Nasal Cavity Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Oropharyngeal Squamous Cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Recurrent Hypopharyngeal Squamous Cell Carcinoma
  • Recurrent Laryngeal Squamous Cell Carcinoma
  • Recurrent Nasal Cavity Squamous Cell Carcinoma
  • Recurrent Oral Cavity Squamous Cell Carcinoma
  • Recurrent Oropharyngeal Squamous Cell Carcinoma
  • Stage III Laryngeal Cancer AJCC v8
  • Stage III Lip and Oral Cavity Cancer AJCC v8
  • Stage III Nasopharyngeal Carcinoma AJCC v8
  • Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8
  • Stage IVA Laryngeal Cancer AJCC v8
  • Stage IVA Lip and Oral Cavity Cancer AJCC v8
  • Stage IVA Nasopharyngeal Carcinoma AJCC v8
  • Stage IVB Laryngeal Cancer AJCC v8
  • Stage IVB Lip and Oral Cavity Cancer AJCC v8
Interventions
  • PROCEDURE
  • BIOLOGICAL
No Results Yet
NCT06974136 | COMPLETED | NA
45 participants

tES Modalities for the Treatment of ADHD

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-03-30
Completion:
2026-03-01
Conditions
  • Attention Deficit Disorder With Hyperactivity
  • Neurodevelopmental Disorders
Interventions
  • DEVICE
No Results Yet
NCT06915025 | RECRUITING | PHASE3
500 participants

Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-04
Start Date:
2025-07-09
Completion:
2032-10-31
Conditions
  • Epithelial Ovarian Cancer
  • Ovarian Cancer
  • Fallopian Tube Cancer
  • Primary Peritoneal Carcinoma
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page